Abiopharma

🔍 GASAWAY SHARILYN S (Director)

Company: GENESIS ENERGY LP (GEL)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 2,491 shares of Common Units - Class A (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 290,855.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Sold 2,491 shares of Common Units - Class A at $17.88 per share (Direct)
  Date: 2026-04-01 | Code: D | equity_swap_involved: 0 | shares_owned_after: 288,364.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Sold 2,491 shares of Phantom Units (Derivative)
  Date: 2026-04-01 | Code: M | Expires: 2026-04-01 | Exercise: 2026-04-01 | equity_swap_involved: 0 | shares_owned_after: 7,670.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 2,393 shares of Phantom Units (Derivative)
  Date: 2026-04-01 | Code: A | Expires: 2027-04-01 | Exercise: 2027-04-01 | equity_swap_involved: 0 | shares_owned_after: 10,063.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: The payment of the phantom units in cash is deemed to be a disposition of the phantom units in exchange for the acquisition of the underlying Common Units - Class A and a simultaneous disposition of the underlying Common Units - Class A to the issuer.
• F2: Upon vesting, the phantom units were paid in cash based on the average closing price of the Common Units - Class A for the 20 trading days immediately prior to the date of vesting.
• F3: The phantom units will be paid in cash based on the average closing price of the Common Units - Class A for the 20 trading days immediately prior to the vesting date.
• F4: Award includes tandem distribution equivalent rights pursuant to which the quarterly distributions paid by the partnership on each Common Unit - Class A will be accrued over the vesting period and paid quarterly.